1. (a) M. Sani, C. Candiani, F. Pecker, L. Malpezzi and M. Zanda, Tetrahedron Lett., 2005, 46, 2393; (b) C. Sun, S. E. Aspland, C. Ballatore, R. Castillo, A. B. Smith, III and A. J. Castellino, Bioorg. Med. Chem. Lett., 2006, 16, 104; (c) B. N. Naidu, M. E. Sorenson, J. J. Bronson, M. J. Pucci, J. M. Clark and Y. Ueda Bioorg. Med. Chem. Lett., 2005, 15, 2069.
2. (a) A. W. Czarnik, Acc. Chem. Res., 1996, 29, 112; (b) N. Nguyen-Ba, W. L. Brown, L. Chan, N. Lee, L. Brasili, D. Lafleur and B. Zacharie, Chem. Commun., 1999, 1245; (c) T. Ashizawa, K. Kawashima, Y. Kanda, K. Gomi, M. Okabe, K. Ueda and T. Tamaoki, Anti-Cancer Drugs, 1999, 10, 829; (d) P. M. Dewick, Medicinal Natural Products 2nd ed.; John Wiley & Sons: West Sussex, UK, 2002; (e) R. Vardanyan and V. Hruby, Synthesis of Essential Drugs 1st ed., Elsevier: Amsterdam, 2006; (f) I. H. Hall, K. –H. Lee, E. C. Mar, C. O. Starnes and T. G. Waddell, J. Med. Chem., 1977, 20, 333.
3. (a) P. Bakuzis and M. L. F. Bakuzis, J. Org. Chem., 1981, 46, 235
4. (b) J. P. Cherkauskas, T. Cohen, J. Org. Chem., 1992, 57, 6.
5. (a) M. Abbasi, Tetrahedron Lett., 2012, 53, 3683